about
Preventing stem cell transplantation-associated viral infections using T-cell therapyPolyomavirus-Specific Cellular Immunity: From BK-Virus-Specific Cellular Immunity to BK-Virus-Associated Nephropathy?Antiviral T-cell therapyBK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infectionPolyomaviruses and disease: is there more to know than viremia and viruria?Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study.Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host.Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression.Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance.Molecular networks involved in the immune control of BK polyomavirus.Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity.Polyomavirus-associated nephropathyCharacterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses.Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation.Monitoring and managing viral infections in pediatric renal transplant recipients.BK polyomavirus infection and nephropathy: the virus-immune system interplay.Tissue-resident T cells, in situ immunity and transplantation.Polyomavirus BK and prostate cancer: an unworthy scientific effort?Alloimmunity But Not Viral Immunity Promotes Allograft Loss in a Mouse Model of Polyomavirus-Associated Allograft Injury.Bright Field Microscopy to Detect Decoy Cells Due to BK Virus Infection in the Fresh and Unstained Urine Sediment in Kidney Allograft Recipients.Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy.The Loss of BKV-specific Immunity From Pretransplantation to Posttransplantation Identifies Kidney Transplant Recipients at Increased Risk of BKV Replication.Characterization of urinary CD4⁺ and CD8⁺ T cells in kidney transplantation patients with polyomavirus BK infection and allograft rejection.BK polyomavirus-specific cellular immune responses are age-dependent and strongly correlate with phases of virus replication.Inflammatory activation and recovering BKV-specific immunity correlate with self-limited BKV replication after renal transplantation.Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapy.BK polyomavirus in solid organ transplantation.A cautionary tale of BK virus.BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy.Pathology of resolving polyomavirus-associated nephropathy.
P2860
Q26801365-DE0DFC71-53EA-441E-A40E-7D37F5E5B1B9Q26826085-956628CD-AA4F-4FC0-91CE-DFD598F82798Q27028006-26911B63-2BB4-4F6C-B703-3AE89A85D90AQ28070240-00D7B6C5-3660-4CE4-B740-144CD1CC85FCQ28081350-A8E918E0-544E-4760-9D13-01BA9F7ECC1AQ30422449-45EFB780-4A29-4D34-82BF-D2F39A9C2AD3Q33713932-DDB883FE-9366-4D4D-93E2-490FA88FA648Q34273968-1AB37F28-4DC0-46B8-9588-914AF63F5559Q35099077-717D68E0-D770-46FB-8A9B-8B36DA47E2F7Q36153492-903FE0A4-AFFF-4818-AE2D-6EF8E4ED3E2AQ36464463-8BDEA217-EEE3-4237-900E-C694DC467395Q37127201-952EC3AF-70FF-4569-AD04-A86ABFFFBC00Q37195470-55AB0258-69C7-435D-B195-9289BC87DCD0Q37345783-E902D4E5-38C7-4F8E-9D29-1BE5C152AAFBQ37687412-6FBC7FA7-C891-4EC8-9608-69EA24014271Q37848137-6D92B5E4-3962-4196-86C1-E823A8B9AE80Q37879442-709797DB-CD44-4359-B185-5698B5D213C8Q38187175-965F9926-5D2A-49AD-8E00-C7A47ACDA5DDQ38320502-8B124483-81B5-4B1E-9E2E-EAD6812A9C7AQ38723077-4983BDD3-B86D-40E4-A72E-84154E80B32FQ40481310-E37E2CD7-BA23-49C9-8033-09F9D9E5BA31Q41271481-7B0ABB66-5302-4BBC-ACDC-7842BDADCC25Q41385328-D35CED63-ECF3-4A01-99B9-74898F7710EEQ42201895-4D38E1C7-1C23-4E56-A213-844CE8A99CD0Q42225033-F4B6D9F5-2002-4B41-ACD9-8343EE0064CFQ42252894-1A501F0D-F87C-4FE9-846E-3E5C7E8821D0Q42268339-769AE9B4-1EDB-4D93-89AA-014AAC5E76F5Q42272314-38A0D5F8-DC75-4A51-B2DD-3ED69DF6AEB6Q44740386-B1C34913-F6F5-4143-BB8D-AF676284DB50Q45364259-1078A2F5-E136-4A0F-AA4C-CAADE2310C74Q51873284-0BBCF1C0-EA57-45D3-BC0D-A15368FF8FCA
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cellular immune responses to BK virus.
@en
Cellular immune responses to BK virus.
@nl
type
label
Cellular immune responses to BK virus.
@en
Cellular immune responses to BK virus.
@nl
prefLabel
Cellular immune responses to BK virus.
@en
Cellular immune responses to BK virus.
@nl
P2093
P1476
Cellular immune responses to BK virus.
@en
P2093
Fabrizio Ginevri
Hans H Hirsch
Patrizia Comoli
P304
P356
10.1097/MOT.0B013E3283186B93
P577
2008-12-01T00:00:00Z